Keyphrases
New Drug Targets
100%
Endometrial Cancer
100%
Targeted Therapy
40%
Molecular Analysis
40%
Tailored Therapy
40%
Sequence Analysis
20%
Tumor
20%
Immune Checkpoint Inhibitors
20%
Treatment Options
20%
Metastatic Disease
20%
Clinical Practice Guidelines
20%
Expert Opinion
20%
Area Cover
20%
Adjuvant Therapy
20%
Early Endometrial Cancer
20%
Surgical Management
20%
Genome Sequencing
20%
Significant Benefit
20%
Oncological Outcomes
20%
Gynecologic Malignancies
20%
Increasing Trends
20%
Prognostic Role
20%
Primary Disease
20%
Risk Classification
20%
Molecular Classification
20%
Molecular Signature
20%
Trends in Incidence
20%
Metastatic Stage
20%
Molecular Treatment
20%
Substratification
20%
Cancer Precision Medicine
20%
Molecular Classes
20%
Medicine and Dentistry
Uterine Cancer
100%
Disease
16%
Neoplasm
16%
Protein P53
16%
Metastatic Carcinoma
16%
Personalized Medicine
16%
Cancer
16%
Prognostication
16%
Immune Checkpoint Inhibitor
16%
Genome Sequencing
16%
Adjuvant Therapy
16%
Surgery
16%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
100%
Immune Checkpoint Inhibitor
16%
Metastasis
16%
Protein P53
16%
Disease
16%
Neoplasm
16%